Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > maybe,maybe,maybe

<< Previous

Bullboard Posts

Next >>

Post by Daregon Jul 07, 2021 9:25am

373 Views

Post# 33504485

maybe,maybe,maybe

Maybe, Sirona will sell off TFC 1067 and if they are smart , retain a small royalty . This would keep their hand in regarding the molecule and provide much needed cash for future perks and bonuses.

Considering that we are left in the dark , regarding details on anything within Sirona, just let your imagination run wild. You could just guess at what outlandish direction this soap opera takes next.

JMHO

<< Previous

Bullboard Posts

Next >>

Transportation technology stock secures second major contract in a week